- Home
- PLRX vs FRPH Comparison
PLRX vs FRPH Comparison
Compare PLRX & FRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRX
- FRPH
- Stock Information
- Founded
- PLRX 2015
- FRPH 1986
- Country
- PLRX United States
- FRPH United States
- Employees
- PLRX N/A
- FRPH N/A
- Industry
- PLRX Biotechnology: Pharmaceutical Preparations
- FRPH Real Estate
- Sector
- PLRX Health Care
- FRPH Finance
- Exchange
- PLRX Nasdaq
- FRPH Nasdaq
- Market Cap
- PLRX 680.3M
- FRPH 576.6M
- IPO Year
- PLRX 2020
- FRPH N/A
- Fundamental
- Price
- PLRX $11.37
- FRPH $30.54
- Analyst Decision
- PLRX Strong Buy
- FRPH
- Analyst Count
- PLRX 7
- FRPH 0
- Target Price
- PLRX $40.50
- FRPH N/A
- AVG Volume (30 Days)
- PLRX 485.5K
- FRPH 27.0K
- Earning Date
- PLRX 02-26-2025
- FRPH 03-05-2025
- Dividend Yield
- PLRX N/A
- FRPH N/A
- EPS Growth
- PLRX N/A
- FRPH 45.62
- EPS
- PLRX N/A
- FRPH 0.40
- Revenue
- PLRX N/A
- FRPH $31,414,000.00
- Revenue This Year
- PLRX N/A
- FRPH N/A
- Revenue Next Year
- PLRX N/A
- FRPH N/A
- P/E Ratio
- PLRX N/A
- FRPH $76.97
- Revenue Growth
- PLRX N/A
- FRPH 4.04
- 52 Week Low
- PLRX $10.22
- FRPH $26.99
- 52 Week High
- PLRX $18.00
- FRPH $33.00
- Technical
- Relative Strength Index (RSI)
- PLRX 44.60
- FRPH 54.78
- Support Level
- PLRX $10.35
- FRPH $30.50
- Resistance Level
- PLRX $11.07
- FRPH $31.39
- Average True Range (ATR)
- PLRX 0.61
- FRPH 0.59
- MACD
- PLRX 0.06
- FRPH 0.11
- Stochastic Oscillator
- PLRX 43.50
- FRPH 69.65
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).